Reviluamide Tablets: A Precision-Targeted New Option for Prostate Cancer Treatment
Prostate cancer is one of the most common malignant tumors of the male reproductive system. Among them, metastatic hormone-sensitive prostate cancer (mHSPC) is characterized by rapid disease progression and high treatment complexity, making it a long-standing focus and challenge in clinical practice. As a novel androgen receptor inhibitor independently developed in China, Reviluamide Tablets (...
0 Comments 0 Shares 43 Views 0 Reviews
Sponsored
Sponsored
Sponsored